8. Stockholders' Equity (Details Narrative) |
3 Months Ended | 9 Months Ended |
|---|---|---|
|
Sep. 30, 2015
USD ($)
$ / shares
shares
|
Sep. 30, 2015
USD ($)
$ / shares
shares
|
|
| Warrant exercise price per share | $ / shares | $ .20 | $ .20 |
| Warrants [Member] | ||
| Warrant issued, common shares available to purchase | 10,000,000 | 10,000,000 |
| Exercisable date | Jan. 01, 2016 | |
| Debt discount warrants | $ | $ 1,600,000 | $ 1,600,000 |
| Value of warrants issued | $ | $ 1,600,000 | $ 1,600,000 |
| Warrants [Member] | Consultant | ||
| Warrant issued, common shares available to purchase | 1,000,000 | 1,000,000 |
| Warrant exercise price per share | $ / shares | $ .77 | $ .77 |
| Value of warrants issued | $ | $ 272,000 | $ 272,000 |
| Warrants [Member] | Collaborative Partners | ||
| Warrant issued, common shares available to purchase | 10,425,000 | 10,425,000 |
| Tax expense associated with warrants | $ | $ 243,000 | $ 336,000 |
| Warrants [Member] | Non-employee director | ||
| Warrant issued, common shares available to purchase | 1,600,000 | 1,600,000 |
| X | ||||||||||
- Definition Date the warrants or rights are exercisable, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|